New EU API equivalency rules: India gets running shoes on over written confirmations
This article was originally published in SRA
India's Central Drugs Standard Control Organization may halve the time it was originally planning to take to issue the written confirmations that local manufacturers of active pharmaceutical ingredients (APIs) will need to export their products to Europe under a new EU rule that will come into effect on 2 July1-3.
You may also be interested in...
While the Dutch government negotiates an acceptable price for Leadiant Biosciences’ orphan drug CDCA, a university hospital has resumed supplying pharmacy compounded versions of the drug after addressing initial problems with the sourcing of raw materials.
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.